Rimidi Diabetes
Latest round
- Series A
Last raised
- Jul 2018
Total raised
- $7.9M
Investors
- 5
About Rimidi Diabetes
Rimidi Diabetes Inc.Founded in 2012 and headquartered in Atlanta, US, Rimidi Diabetes Inc. specializes in chronic disease management solutions. The company was co-founded by Lucienne Ide, who has a background in healthcare technology.Rimidi specializes in chronic disease management and remote patient monitoring through an integrated software platform designed to work seamlessly with existing electronic health records (EHR). Their offerings include configurable Remote Patient Monitoring (RPM) programs featuring enhanced decision support and patient prioritization.Rimidi generates revenue through a subscription-based model targeting healthcare providers and institutions utilizing their platform for chronic disease management. Clients subscribe for access to the software and tools, enabling long-term business-to-business (B2B) partnerships focused on enhancing patient care and outcomes. The focus remains on improving chronic disease management, with particular emphasis on better outcomes for patients managing type 2 diabetes.
Who invested in Rimidi Diabetes
5 investors across 2 rounds
See all investors in Rimidi Diabetes
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rimidi Diabetes
Who invested in Rimidi Diabetes?
Rimidi Diabetes has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rimidi Diabetes raised?
Rimidi Diabetes has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Rimidi Diabetes last raise money?
Rimidi Diabetes's most recent round on record is a Series A, in Jul 2018.
What does Rimidi Diabetes do?
Rimidi Diabetes is a software company.
Where is Rimidi Diabetes headquartered?
Rimidi Diabetes is headquartered in Atlanta, US.
Which VCs invest in companies like Rimidi Diabetes?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Rimidi Diabetes's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like Rimidi Diabetes? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.